TD Cowen Lowers P3 Health Partners (NASDAQ:PIII) Price Target to $3.00

P3 Health Partners (NASDAQ:PIII) had its price target reduced by TD Cowen from $8.00 to $3.00 in a research report issued on Thursday,Benzinga reports. The brokerage presently has a “hold” rating on the stock. TD Cowen’s price target indicates a potential upside of 16.73% from the stock’s current price.

A number of other brokerages have also recently commented on PIII. BTIG Research restated a “neutral” rating on shares of P3 Health Partners in a research note on Friday, December 12th. Weiss Ratings reaffirmed a “sell (e+)” rating on shares of P3 Health Partners in a research report on Thursday, January 22nd. Finally, Lake Street Capital dropped their target price on P3 Health Partners from $12.50 to $4.00 and set a “buy” rating on the stock in a research report on Friday, March 27th. One investment analyst has rated the stock with a Buy rating, two have given a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat, P3 Health Partners presently has a consensus rating of “Hold” and an average target price of $3.50.

P3 Health Partners Price Performance

P3 Health Partners stock opened at $2.57 on Thursday. The firm has a fifty day moving average of $2.46 and a 200-day moving average of $4.99. P3 Health Partners has a 52-week low of $1.52 and a 52-week high of $11.30. The firm has a market capitalization of $18.52 million, a P/E ratio of -0.06 and a beta of 0.57.

P3 Health Partners (NASDAQ:PIII) last posted its earnings results on Thursday, March 26th. The company reported ($23.02) earnings per share for the quarter, missing the consensus estimate of ($8.06) by ($14.96). P3 Health Partners had a negative net margin of 10.14% and a negative return on equity of 302.33%. The business had revenue of $384.81 million for the quarter, compared to analyst estimates of $357.65 million. On average, research analysts expect that P3 Health Partners will post -0.67 EPS for the current fiscal year.

Institutional Investors Weigh In On P3 Health Partners

A hedge fund recently raised its stake in P3 Health Partners stock. Trinity Financial Advisors LLC raised its stake in P3 Health Partners Inc. (NASDAQ:PIII) by 4.6% during the third quarter, according to its most recent disclosure with the SEC. The fund owned 26,678 shares of the company’s stock after buying an additional 1,178 shares during the quarter. Trinity Financial Advisors LLC owned approximately 0.37% of P3 Health Partners worth $239,000 as of its most recent SEC filing. Hedge funds and other institutional investors own 7.75% of the company’s stock.

About P3 Health Partners

P3 Health Partners is a healthcare technology and services company that delivers data-driven solutions to support health plans in improving quality measures, risk adjustment accuracy and operational efficiency. The company’s platform integrates advanced analytics, reporting capabilities and workflow automation to help clients optimize performance across value-based care programs and regulatory requirements.

The company’s core offerings include quality measurement and reporting for HEDIS, STAR and other performance frameworks, risk adjustment coding and audit services, and population health analytics.